Motoo Y, Sawabu N
Department of Internal Medicine, Kanazawa University, Japan.
Cancer Lett. 1994 Oct 28;86(1):91-5. doi: 10.1016/0304-3835(94)90184-8.
Antitumor effects of nine components of a herbal medicine, 'Sho-saiko-to', were investigated on human hepatoma cell lines (PLC/PRF/5, Hep-G2), human liver cells (Chang) and a human pancreatic cancer cell line (BxPC-3). The concentration of each component required for 50% inhibition of cell growth of PLC/PRF/5 cells was as follows: saikosaponin-d, baicalin, 20 micrograms/ml; saikosaponin-a, baicalein, 50 micrograms/ml; saikosaponin-b2, -c, ginsenoside-Rb1, -Rg1, glycyrrhizin, > 1000 micrograms/ml. Saikosaponin-a in 50-micrograms/ml quantities inhibited the cell growth and DNA synthesis of all the cell lines tested. These results indicate that 'Sho-saiko-to' includes potent antitumor components such as saikosaponin-a, -d, baicalin against human hepatoma cells as well as other human cell lines.
研究了中药“小柴胡汤”的九种成分对人肝癌细胞系(PLC/PRF/5、Hep-G2)、人肝细胞(Chang)和人胰腺癌细胞系(BxPC-3)的抗肿瘤作用。抑制PLC/PRF/5细胞生长50%所需的每种成分浓度如下:柴胡皂苷d、黄芩苷,20微克/毫升;柴胡皂苷a、黄芩素,50微克/毫升;柴胡皂苷b2、-c、人参皂苷-Rb1、-Rg1、甘草酸,>1000微克/毫升。50微克/毫升的柴胡皂苷a抑制了所有测试细胞系的细胞生长和DNA合成。这些结果表明,“小柴胡汤”含有对人肝癌细胞以及其他人类细胞系有效的抗肿瘤成分,如柴胡皂苷a、-d、黄芩苷。